About Matthew Head
Matthew Head is an executive officer at Solaris Endovascular.
Form D filings also name Matthew Head as a chief financial officer at OncoNano.
Matthew Head first appears on SEC filings in 2019.
Experience
This experience comes from Matthew Head's profile and from SEC filings. For roles taken from filings, the years are when the filings name Matthew Head in the role, so the role may have started earlier or lasted longer.
Solaris Endovascular Inc. Current
CFO
2026 – Present · Dallas, TX
Develops covered stents for patients with dialysis access problems and peripheral artery disease.
SB
SingleCell Biotechnology Current
Board Member
2025 – Present
CL
Consultants in Finance, LLC Current
Founder
2014 – Present
OncoNano Medicine, Inc.
CFO
2018 – 2026 · Dallas, TX
Develops experimental cancer treatments and drug delivery technology for patients with cancer.
ZI
ZS Pharma, Inc.
Vice President, Head of Finance
2014 – 2018
AI
Alcon Laboratories, Inc.
Director, Corporate Giving
1998 – 2014
EI
Elenza, Inc.
Member Board of Directors
2010 – 2012
WB
Wells Fargo Bank
Vice President, Commercial Lending
1995 – 1998
SB
SunTrust Bank
Assistant Vice President, Commercial Lending
1989 – 1995
Key Colleagues at Startups
The people Matthew Head works with at each company, as listed on that company's latest Form D.
Solaris Endovascular Inc. · Form D, Oct 1, 2026
RH
Randolph Hubbell
Chief Executive Officer and director
AM
Alexander Moreira
Director
MN
Melchiades Neto
Director
MC
Marco Costa
Chief Scientific & Medical Officer, director
DS
David Stack
Director
OncoNano Medicine, Inc. · Form D, Jun 2, 2025
JD
John Dyett
Co-Founder and Managing Director
GJ
Gina Jones
Director
MP
Melissa Paoloni
Executive officer
Brett Giroir
Chairman & Interim CEO
YQ
Yumin Qui
Director
KK
Kartik Krishnan
Executive officer and director